Thiolated nanoparticles overcome the mucus barrier and epithelial barrier for oral delivery of insulin.
Oral administration is an ideal alternative for drug delivery due to its convenience and safety. However, oral protein delivery is limited by biological barriers such as mucus barrier and epithelial barrier, which hamper drugs entering the blood successfully. Here we presented PC6/CS NPs, which is a thiolated polymer based nano-drug delivery system in the form of PAA-Cys-6MNA (PC6) coating on chitosan (CS) nanoparticles, and investigated its ability to overcome mucus barrier and epithelial barrier. The existence of PC6 made the NPs prone to penetrate mucus layer as well as strengthened the transcellular transport of insulin on epithelial cells. PC6/CS NPs efficiently enhanced the oral bioavailability of insulin to 16.2%. The improvement resulted from the function of PC6: (1) "diluting" mucus to promote nanoparticles penetration, (2) opening tight junction to help insulin transport via paracellular pathway, (3) making the nanoparticle more electrical neutrality during the penetration process and (4) uncoated from PC6/CS NPs so that positive CS NPs exposed to adhere and uptake by epithelial cells. Our study proves that PC6/CS NPs, which can achieve mucus penetration and epithelial permeation efficiently, is a potential nanocarrier for oral protein delivery.